177 related articles for article (PubMed ID: 17053859)
1. Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18]fluoro-D: -glucose Injection following I.V. Insulin in diabetic patients.
Turcotte E; Leblanc M; Carpentier A; Bénard F
Mol Imaging Biol; 2006; 8(6):348-54. PubMed ID: 17053859
[TBL] [Abstract][Full Text] [Related]
2. Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients.
Roy FN; Beaulieu S; Boucher L; Bourdeau I; Cohade C
J Nucl Med; 2009 Feb; 50(2):178-83. PubMed ID: 19164226
[TBL] [Abstract][Full Text] [Related]
3. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
4. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
5. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
[TBL] [Abstract][Full Text] [Related]
6. Effect of insulin on uptake of FDG by experimental mammary carcinoma in diabetic rats.
Torizuka T; Fisher SJ; Brown RS; Wahl RL
Radiology; 1998 Aug; 208(2):499-504. PubMed ID: 9680582
[TBL] [Abstract][Full Text] [Related]
7. Differential background clearance of fluorodeoxyglucose activity in normal tissues and its clinical significance.
Cheng G; Alavi A; Lee NJ; Akers SR
PET Clin; 2014 Apr; 9(2):209-16. PubMed ID: 25030283
[TBL] [Abstract][Full Text] [Related]
8. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
[TBL] [Abstract][Full Text] [Related]
9. Does diabetes affect [(18)F]FDG standardised uptake values in lung cancer?
Gorenberg M; Hallett WA; O'Doherty MJ
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1324-7. PubMed ID: 12271414
[TBL] [Abstract][Full Text] [Related]
10. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
Kramer GM; Frings V; Hoetjes N; Hoekstra OS; Smit EF; de Langen AJ; Boellaard R
J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020
[TBL] [Abstract][Full Text] [Related]
11. Altered biodistribution of FDG in patients with type-2 diabetes mellitus.
Ozguven MA; Karacalioglu AO; Ince S; Emer MO
Ann Nucl Med; 2014 Jul; 28(6):505-11. PubMed ID: 24652347
[TBL] [Abstract][Full Text] [Related]
12. Influence of subcutaneous administration of rapid-acting insulin in the quality of (18)F-FDG PET/CT studies.
Garcia JR; Sanchis A; Juan J; Tomas J; Domenech A; Soler M; Moragas M; Riera E
Nucl Med Commun; 2014 May; 35(5):459-65. PubMed ID: 24535382
[TBL] [Abstract][Full Text] [Related]
13. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT.
Büsing KA; Schönberg SO; Brade J; Wasser K
Nucl Med Biol; 2013 Feb; 40(2):206-13. PubMed ID: 23228852
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of organ-specific glucose metabolism by ¹⁸F-FDG in insulin receptor substrate-1 (IRS-1) knockout mice as a model of insulin resistance.
Cheng C; Nakamura A; Minamimoto R; Shinoda K; Tateishi U; Goto A; Kadowaki T; Terauchi Y; Inoue T
Ann Nucl Med; 2011 Dec; 25(10):755-61. PubMed ID: 21818569
[TBL] [Abstract][Full Text] [Related]
15. Validation for performing ¹¹C-methionine and ¹⁸F-FDG-PET studies on the same day.
Mitsumoto T; Kubota K; Sato T; Morooka M; Minamimoto R; Shimbo T; Muramatsu Y; Sasaki T; Ito K; Fukushi M
Nucl Med Commun; 2012 Mar; 33(3):297-304. PubMed ID: 22107999
[TBL] [Abstract][Full Text] [Related]
16. Standardized uptake values of normal breast tissue with 2-deoxy-2-[F-18]fluoro-D: -glucose positron emission tomography: variations with age, breast density, and menopausal status.
Kumar R; Chauhan A; Zhuang H; Chandra P; Schnall M; Alavi A
Mol Imaging Biol; 2006; 8(6):355-62. PubMed ID: 17053861
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.
Minn H; Zasadny KR; Quint LE; Wahl RL
Radiology; 1995 Jul; 196(1):167-73. PubMed ID: 7784562
[TBL] [Abstract][Full Text] [Related]
19. Effective reduction of brown fat FDG uptake by controlling environmental temperature prior to PET scan: an expanded case series.
Garcia C; Bandaru V; Van Nostrand D; Chennupati S; Atkins F; Acio E; Kulkarni K; Majd M
Mol Imaging Biol; 2010 Dec; 12(6):652-6. PubMed ID: 20237858
[TBL] [Abstract][Full Text] [Related]
20. Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the "glucose-corrected" SUV.
Hadi M; Bacharach SL; Whatley M; Libutti SK; Straus SE; Rao VK; Wesley R; Carrasquillo JA
Nucl Med Biol; 2008 May; 35(4):441-5. PubMed ID: 18482681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
